178 results
8-K
EX-10.2
ASMB
Assembly Biosciences, Inc.
18 Jun 24
Assembly Biosciences Announces $12.6 Million in Equity Financings
4:07pm
, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(h) Material Changes; Undisclosed Events, Liabilities … control over financial reporting. The Company’s auditors and the audit
committee of the Company’s board of directors have been advised of: (i) all
8-K
EX-10.1
ASMB
Assembly Biosciences, Inc.
18 Jun 24
Assembly Biosciences Announces $12.6 Million in Equity Financings
4:07pm
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(h) Material Changes; Undisclosed … , the Company’s internal control over financial reporting. The Company’s auditors and the audit committee of the Company’s board of directors have been advised
8-K
220ds5g
15 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
z97gj2
17 Oct 23
Entry into a Material Definitive Agreement
7:10am
8-K
EX-10.2
u8xrhhs3ovi9
17 Oct 23
Entry into a Material Definitive Agreement
7:10am
8-K
EX-3.1
riryqlfj 9esyvo
12 Dec 22
Departure of Directors or Certain Officers
4:05pm